Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 48 - Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
Patents for A61K 48 - Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy (86,964)
12/1999
12/08/1999EP0962463A1 Uncharged morpholino-based polymers having phosphorus-containing chiral intersubunit linkages
12/08/1999EP0961837A1 Three component chimeric antisense oligonucleotides
12/08/1999EP0961830A1 EXPRESSION VECTORS AND METHODS FOR $i(IN VIVO) EXPRESSION OF THERAPEUTIC POLYPEPTIDES
12/08/1999EP0961826A2 Purification and/or concentration of dna by cross-flow filtration, separation of endotoxins from a nucleic acid preparation
12/08/1999EP0961778A1 3-hydroxyacyl-coa dehydrogenase from staphylococcus aureus
12/08/1999EP0522078B1 Gp75 as a tumor vaccine for melanoma
12/08/1999CN1237980A Polypptides comprising GAX protein domains, involved in repressing transcription and/or interacting with other proteins, corresponding nucleic acid and their use
12/08/1999CN1237582A Cancer suppressor action of antisense nucteic acid of para-insulin growth factor receptor gene
12/07/1999US5998602 RNase L activators and antisense oligonucleotides effective to treat RSV infections
12/07/1999US5998600 β-catenin, TCF-4, and APC interact to prevent cancer
12/07/1999US5998599 Growth arrest gene compositions and methods
12/07/1999US5998598 Immunoadhesins and methods of production and use thereof
12/07/1999US5998596 Inhibition of protein kinase activity by aptameric action of oligonucleotides
12/07/1999US5998587 Anti-cyanovirin antibody
12/07/1999US5998583 BH3 interacting domain death agonist
12/07/1999US5998384 Endoscopic administration of an HSV-tk gene to treat digestive organ cancer
12/07/1999US5998205 Vectors for tissue-specific replication
12/07/1999US5998193 Genetic engineering
12/07/1999US5998192 For use in many human gene therapy protocols, especially those requiring transduction of normal or neoplastic haemopoietic cells.
12/07/1999US5998170 Polynucleotides encoding hepatocyte-specific members of the FGF family
12/07/1999US5998164 Polynucleotides encoding human G-protein coupled receptor GPRZ
12/07/1999US5998144 Method for integrating genes at specific sites in mammalian cells via homologous recombination and vectors for accomplishing the same
12/07/1999US5997943 Compound for a non-wettable coating, process for treatment of glass with the aid of the compound and products obtained
12/07/1999US5997881 Method of making non-pyrogenic lipopolysaccharide or A
12/07/1999US5997878 Recombinant poxvirus-cytomegalovirus, compositions and uses
12/07/1999US5997861 Antiviral supramolecules containing target-binding molecules and therapeutic molecules bound to spectrin
12/07/1999US5997859 Gene encoding a conditionally lethal gene product which activates a purine- or pyrimidine-based prodrug into an agent that is cytotoxic to said metastatic carcinoma; and administering said prodrug to said patient
12/07/1999US5997509 Minimally invasive gene therapy delivery device and method
12/02/1999WO1999062315A2 Method for altering the activity of proteins of the pka signaling pathway
12/02/1999WO1999061916A1 Identification of broadly reactive dr restricted epitopes
12/02/1999WO1999061639A2 Retroviral delivery system
12/02/1999WO1999061638A1 Chimeric adenoviral vectors
12/02/1999WO1999061636A1 Recombinant cytomegalovirus expression system targeting the immediate-early gene region
12/02/1999WO1999061628A2 Novel nucleic acids and polypeptides related to a farnesyl-directed endopeptidase
12/02/1999WO1999061618A2 Canine and feline immunoregulatory proteins, nucleic acid molecules, and uses thereof
12/02/1999WO1999061595A2 Adeno-associated viral vector-mediated expression of factor viii activity
12/02/1999WO1999061590A1 Methods and compositions useful for modulation of angiogenesis using tyrosine kinase src
12/02/1999WO1999061589A2 Expansion of hematopoietic stem cells transduced with mdr-1 and methods of use thereof
12/02/1999WO1999061587A1 Human cd45+ and/or fibroblast + mesenchymal stem cells
12/02/1999WO1999061472A1 Cytokine resistant cytomegalovirus promoter mutants and related products and methods
12/02/1999WO1999061462A1 Antisense modulation of cellular adhesion molecule expression and treatment of cellular adhesion molecule-associated diseases
12/02/1999WO1999061069A1 Materials and methods for delivery and expression of heterologous dna in vertebrate cells
12/02/1999WO1999061068A1 Anti-prostate cancer vaccines, and methods of making, using and evaluating the same
12/02/1999WO1999061067A1 Gene expression method
12/02/1999WO1999061066A2 Convection-enhanced delivery of aav vectors
12/02/1999WO1999061065A1 Cd40 binding molecules and ctl peptides for treating tumors
12/02/1999WO1999061063A1 Stable gene preparations
12/02/1999WO1999061057A2 Molecules targeting cd40 and tumor cells
12/02/1999WO1999061051A1 Compositions and methods of modulating an immune response to an antigen
12/02/1999WO1999061046A1 Parasite antigens
12/02/1999WO1999061043A1 Chaperone suppression of ataxin-1 aggregation and altered subcellular proteasome localization imply protein misfolding in sca1
12/02/1999WO1999061034A1 Improved vectors
12/02/1999WO1999061003A1 Drug delivery system comprising a tightly compacted solid medicament stock
12/02/1999WO1999060999A1 Preparations for the application of anti-inflammatory, especially antiseptic agents and/or agents promoting the healing of wounds, to the lower respiratory tract
12/02/1999WO1999060998A1 Preparations for the application of anti-inflammatory, especially antiseptic agents and/or agents promoting the healing of wounds, to the upper respiratory tract and/or the ear
12/02/1999WO1999060986A2 Apoptosis modulators that interact with the huntington's disease gene
12/02/1999WO1999055564A8 Materials and methods for gene therapy
12/02/1999WO1999053942A8 Compositions comprising osteoprotegerin for the prevention and treatment of cardiovascular diseases
12/02/1999WO1999051268A9 Immunomodulatory compositions of mmtv antigens and methods of using same
12/02/1999WO1999050425A3 Regulated apoptosis using chemically induced dimerization of apoptosis factors
12/02/1999WO1999046381A9 Human fgf gene and gene expression products
12/02/1999WO1999043286A3 Isolated stromal cells for use in the treatment of diseases of the central nervous system
12/02/1999WO1999032634A3 Compositions derived from mycobacterium vaccae and methods for their use
12/02/1999WO1999019354A9 Novel vitamin d receptor related polypeptides, nucleic acid sequence encoding the same and uses thereof
12/02/1999DE19824230A1 Neues Endometriose-assoziiertes Gen Create an endometriosis-associated gene
12/02/1999CA2334940A1 Chaperone suppression of ataxin-1 aggregation and altered subcellular proteasome localization imply protein misfolding in sca1
12/02/1999CA2333159A1 Method
12/02/1999CA2332786A1 Identification of broadly reactive dr restricted epitopes
12/02/1999CA2332371A1 Preparations for the application of antiseptic agents and/or agents which promote the healing of wounds, to the lower respiratory tract
12/02/1999CA2332369A1 Drug delivery system comprising a tightly compacted solid medicament stock
12/02/1999CA2331833A1 Parasite antigens
12/02/1999CA2329525A1 Cytokine resistant cytomegalovirus promoter mutants and related products and methods
12/02/1999CA2329249A1 Apoptosis modulators that interact with the huntington's disease gene
12/02/1999CA2329143A1 Adeno-associated viral vector-mediated expression of factor viii activity
12/02/1999CA2329052A1 Canine and feline immunoregulatory proteins, nucleic acid molecules, and uses thereof
12/02/1999CA2328604A1 Compositions and methods of modulating an immune response to an antigen
12/02/1999CA2328524A1 Human cd45+ and/or fibroblast + mesenchymal stem cells
12/02/1999CA2328491A1 Retroviral delivery system
12/02/1999CA2325462A1 Novel nucleic acids and polypeptides related to a farnesyl-directed endopeptidase
12/02/1999CA2298064A1 Chimeric adenoviral vectors
12/01/1999EP0960941A1 Gene Therapy for cell proliferative diseases
12/01/1999EP0960208A1 Glutathione s-transferase (gst) genes in cancer
12/01/1999EP0960205A1 Chain reaction cloning
12/01/1999EP0960204A1 Method and reagents for genetic immunization
12/01/1999EP0960202A1 Monocyte chemotactic protein 5 (mcp-5) molecules and uses therefor
12/01/1999EP0960197A1 GENES FROM 20q13 AMPLICON AND THEIR USES
12/01/1999EP0960192A1 Synthetic polynucleotides
12/01/1999EP0960191A1 Compositions and methods for use of defensin
12/01/1999EP0960123A1 Sprouty protein and coding sequence
12/01/1999EP0960121A1 Peptide nucleic acids having enhanced binding affinity, sequence specificity and solubility
12/01/1999EP0960120A1 MAMMALIAN SEX COMB ON MIDLEG (MAMMALIAN Scm) ACTS AS AN ONCOGENE
12/01/1999EP0960118A1 Nucleotide and protein sequences of liver activin/inhibin and methods based thereon
12/01/1999EP0960117A1 FIBROBLAST GROWTH FACTOR HOMOLOGOUS FACTORS (FHFs) AND METHODS OF USE
12/01/1999EP0960115A1 MAMMALIAN ADDITIONAL SEX COMBS (MAMMALIAN Asx) ACTS AS AN ONCOGENE
12/01/1999EP0959904A2 Hybrid compositions for intracellular targeting
12/01/1999EP0959903A1 NOVEL FabD
12/01/1999CN1237209A Herpesvirus saimiri as viral vector
12/01/1999CN1237161A New amino alcohol derivatives, process for production thereof and medicaments and reagents containing these compounds
12/01/1999CN1237102A Liposomes
11/1999
11/30/1999US5994616 Targeted synthesis of protein in mammary gland of a non-human transgenic mammal
1 ... 735 736 737 738 739 740 741 742 743 744 745 746 747 748 749 750 751 752 753 754 755 ... 870